Name:	prph_LicenseOrRoyaltyNetRevenuePercentage
Namespace Prefix:	prph_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Manufacturing Agreement, Renewal Options

+ References

No definition available.

+ Details

Name:	prph_ManufacturingAgreementRenewalOptions
Namespace Prefix:	prph_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Manufacturing Agreement, Renewal Period

+ References

No definition available.

+ Details

Name:	prph_ManufacturingAgreementRenewalPeriod
Namespace Prefix:	prph_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

Number Of Sites

+ References

No definition available.

+ Details

Name:	prph_NumberOfSites
Namespace Prefix:	prph_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Upfront license fee.

+ References

No definition available.

+ Details

Name:	prph_UpfrontLicenseFee
Namespace Prefix:	prph_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	prph_ArrangementTypeAxis=prph_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=prph_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=prph_PhaseThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=prph_NewDrugApplicationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Narrative (Details) $ in Thousands		3 Months Ended		6 Months Ended
	Jul. 19, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2023 site	May 01, 2021 periods
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Renewal options \| periods							4
Renewal period (in years)							1 year
Agreement term (in days)							90 days
License agreement term (in days)	10 days
General and administrative expense		$ 9,937	$ 6,306	$ 18,235	$ 14,130
Number Of Sites \| site						12
License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
General and administrative expense		$ 500		$ 700
License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront license fee	$ 50
License or royalty net revenue percentage	3.00%
Royalty expense	$ 250
License Agreement \| Phase 3
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Additional payment of fee	900
License Agreement \| New Drug Application
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Additional payment of fee	$ 1,000